Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9122 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8874 |
High Similarity |
NPD3882 |
Suspended |
0.8867 |
High Similarity |
NPD2801 |
Approved |
0.88 |
High Similarity |
NPD1934 |
Approved |
0.8767 |
High Similarity |
NPD1511 |
Approved |
0.8714 |
High Similarity |
NPD943 |
Approved |
0.8714 |
High Similarity |
NPD1240 |
Approved |
0.8649 |
High Similarity |
NPD1512 |
Approved |
0.8627 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD1510 |
Phase 2 |
0.8592 |
High Similarity |
NPD1607 |
Approved |
0.8581 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD4380 |
Phase 2 |
0.8471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8392 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8375 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8365 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8288 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8258 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8231 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8224 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8163 |
Intermediate Similarity |
NPD2796 |
Approved |
0.816 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8146 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8141 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8121 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.811 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8098 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8089 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8071 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8054 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7973 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7952 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7931 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7872 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7847 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7829 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD919 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7792 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7733 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7682 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7679 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7654 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7643 |
Intermediate Similarity |
NPD920 |
Approved |
0.764 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7632 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7625 |
Intermediate Similarity |
NPD37 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7571 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7533 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7532 |
Intermediate Similarity |
NPD5403 |
Approved |
0.753 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7425 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7394 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7384 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7372 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7345 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7329 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7317 |
Intermediate Similarity |
NPD5353 |
Approved |
0.731 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7266 |
Intermediate Similarity |
NPD228 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD1201 |
Approved |
0.719 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7172 |
Intermediate Similarity |
NPD17 |
Approved |
0.7163 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7117 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD824 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7088 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7075 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1281 |
Approved |
0.707 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7065
|
Intermediate Similarity |
NPD6782 |
Approved |